Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
for
Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma,
Location: Boston MA, Providence RI, New York NY, Hackensack NJ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06564038
Phase 1, Phase 2, Recruiting
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
for
Hemorrhagic Shock, Trauma Injury
Location: Washington D.C. DC, Wake Forest NC, Pittsburgh PA,
Sponsor: Philip Spinella
Sex: All
Age: 0 - 17
Code: NCT06070350
Phase 3, Recruiting
Assessing Patient Satisfaction and Confidence After Use of Educational Video to Augment Surgical Consent for Thyroid Surgery
for
Thyroid Cancer
Location: Philadelphia PA
Sponsor: Thomas Jefferson University
Sex: All
Age: 18+
Code: NCT06918223
Recruiting
A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
for
Cystic Fibrosis
Location: Boston MA, New York NY, Philadelphia PA, Kansas City KS
Sponsor: Spirovant Sciences, Inc.
Sex: All
Age: 18 - 65
Code: NCT06526923
Phase 1, Phase 2, Recruiting
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
for
Cystic Fibrosis
Location: Boston MA, Valhalla NY, New York NY, Burlington VT,
Sponsor: Sonya Heltshe
Sex: All
Age: 0 - 10
Code: NCT04509050
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Cryoablation of Small Breast Tumors in Early Stage Breast Cancer
Location: Philadelphia PA, Miami FL, Buffalo NY, Cleveland OH,
Sponsor: Oncotartis, Inc.
Sex: All
Age: 18+
Code: NCT03921879
Phase 1, Recruiting
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
for
Relapsed or Refractory Multiple Myeloma (RRMM)
Location: Halifax, Boston MA, New York NY, Montreal,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06615479
Phase 3, Recruiting
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
for
Breast Neoplasms, Breast Cancer, Breast Tumors, Angiosarcoma,
Location: New Haven CT, The Bronx NY, New York NY,
Sponsor: QuantumLeap Healthcare Collaborative
Sex: All
Age: 18+
Code: NCT01042379
Phase 2, Recruiting
Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY)
for
Chemotherapy-induced Peripheral Neuropathy
Location: Burlington VT, Philadelphia PA, Baltimore MD,
Sponsor: Disarm Therapeutics
Sex: All
Age: 18+
Code: NCT03997981
Recruiting
Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix
for
Cervical Cancer by FIGO Stage 2018
Location: Philadelphia PA, Burmingham AL, Little Rock AR,
Sponsor: Varian, a Siemens Healthineers Company
Sex: Female
Age: 18+
Code: NCT05197881
Recruiting
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
for
Low Grade Serous Ovarian Cancer
Location: New Haven CT, New York NY, Montreal, Philadelphia PA,
Sponsor: Verastem, Inc.
Sex: Female
Age: 18+
Code: NCT06072781
Phase 3, Recruiting
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
Emphysema Research Registry and Biosample Repository
for
Emphysema, Chronic Obstructive Pulmonary Disease,
Location: Pittsburgh PA
Sponsor: University of Pittsburgh
Sex: All
Age: 21+
Code: NCT00307281
Recruiting
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers